| Unique ID issued by UMIN | UMIN000055535 |
|---|---|
| Receipt number | R000062788 |
| Scientific Title | Long-Term Safety Confirmation Trial of a Test Food Product |
| Date of disclosure of the study information | 2024/09/18 |
| Last modified on | 2024/09/18 19:18:32 |
Long-Term Safety Confirmation Trial of a Test Food Product
Long-Term Safety Confirmation Trial of a Test Food Product
Long-Term Safety Confirmation Trial of a Test Food Product
Long-Term Safety Confirmation Trial of a Test Food Product
| Japan |
Male/female adults
| Adult |
Others
NO
To verify the safety of long-term consumption (12 weeks) of the test food.
Safety
Adverse events and side effects
Changes in clinical laboratory values
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
| Food |
Consumption of the test food (1 capsule a day) for 12 weeks
| 20 | years-old | <= |
| 65 | years-old | > |
Male and Female
1. Men and women aged 20 to below 65 years at the time of consent acquisition.
2. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.
1. Subjects who regularly consume Foods for Specified Health Uses (FOSHU), Foods with Functional Claims, or health supplements (including those that may affect sleep, stress, or gut health) three or more times per week and cannot stop consuming them from the time of consent acquisition.
2. Subjects who are taking medications that may affect sleep, stress, or gut health and cannot restrict their use from the time of consent acquisition.
3. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials.
4. Subjects with excessive alcohol intake.
5. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs.
6. Females who are pregnant or lactating, and females who could become pregnant during trial period.
7. Subjects with allergies to medications and/or food.
8. Subjects who donated blood or component (200 mL) within the last 1 months.
9. Subjects who donated his blood (400 mL) within the last 3 months.
10. Subjects who donated her blood (400 mL) within the last 4 months.
11. Subjects who being collected in total of his blood (1200 mL) within the last 12 months and in this study.
12. Subjects who being collected in total of her blood (800 mL) within the last 12 months and in this study.
13. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
20
| 1st name | Fumiko |
| Middle name | |
| Last name | Nakamura |
CPCC Company Limited
Clinical Support Department
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan
03-6225-9001
cpcc-contact@cpcc.co.jp
| 1st name | Masanori |
| Middle name | |
| Last name | Numa |
CPCC Company Limited
Clinical Planning Department
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan
03-6225-9001
cpcc-contact@cpcc.co.jp
CPCC Company Limited
MEGMILK SNOW BRAND Co.,Ltd
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
| 2024 | Year | 09 | Month | 18 | Day |
Unpublished
Preinitiation
| 2024 | Year | 07 | Month | 29 | Day |
| 2024 | Year | 07 | Month | 26 | Day |
| 2024 | Year | 09 | Month | 18 | Day |
| 2025 | Year | 01 | Month | 20 | Day |
| 2024 | Year | 09 | Month | 18 | Day |
| 2024 | Year | 09 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062788